Sputnik V Vaccine Arrives in Mexico

The Russian Direct Investment Fund (RDIF) announced the delivery of the first batch of the Sputnik V vaccine in Mexico. This shipment of Sputnik V is sufficient to vaccinate 200,000 people.

Previously, the Federal Commission for the Protection against Sanitary Risk of Mexico (COFEPRIS) approved Sputnik V under the emergency use authorization procedure on February 3, 2021. Mexico has become the first country of North America to approve Sputnik V.

Kirill Dmitriev, CEO of the RDIF, commented in a press statement, “Cooperation between Russia and Mexico on the vaccine is a great example of pooling efforts to jointly fight the pandemic and save lives. The positive decision of COFEPRIS to grant an emergency use authorization to Sputnik V provides people of Mexico with access to one of the best vaccines in the world.”

The Sputnik V vaccine, an adenoviral-based vaccine against the SARS-CoV-2 coronavirus, is approved for use in more than 30 countries globally.